← Back to Search

Individuals with primary psychotic disorders for Schizophreniform Disorder

N/A
Recruiting
Led By Agnes Kalinowski, MD/PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

The investigators are seeking healthy volunteers and people with schizophrenia or schizoaffective disorder for a clinical study of the immune system in psychotic disorders. This is an observational study, to understand the ways in which the immune system may be contributing to the disease process.

Eligible Conditions
  • Schizophreniform Disorder
  • Schizophrenia
  • Schizoaffective Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Group comparison of C4 protein in immune cells
Secondary outcome measures
Body Mass Index and its relationship to C4 protein concentration
C4 Activation
C4 Gene Copy Number
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Individuals with primary psychotic disordersExperimental Treatment7 Interventions
Participants who have received any of the following diagnoses: schizophrenia, schizoaffective disorder, or schizophreniform disorder. Participants will have urine toxicology screen, vitals recorded, and blood drawn in a single visit.
Group II: Healthy ControlsExperimental Treatment7 Interventions
Healthy participants who do not have any exclusion criteria will undergo an assessment to confirm absence of psychiatric disorder. Participants will have urine toxicology screen, vitals recorded, and blood drawn in a single visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitals
2016
Completed Phase 4
~30

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,410 Previous Clinical Trials
17,462,809 Total Patients Enrolled
Agnes Kalinowski, MD/PhDPrincipal InvestigatorClinical Professor of Psychiatry and Behavior Sciences
Jong Yoon, MDPrincipal InvestigatorProfessor of Psychiatry and Behavior Sciences
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top